U.S. Department of Defense awards $11.9 million to OSU for drug delivery research

The U.S. Department of Defense has awarded up to $11.9 million to Oregon State University to invent new drug delivery technologies for protecting members of the military from a range of health threats in combat areas.

New Bispecific Antibody Approved for Tough-to-Treat Lymphoma

The FDA has granted accelerated approval to glofitamab (Columvi) for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), Genentech, the drug’s developer, announced

June 17, 2023

Weight loss startup Calibrate raises $29M as part of private equity restructuring

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Calibrate, the weight loss startup that rose

November 2, 2023

Psyence Group Announces Closing of Private Placement & Conclusion of Loan Agreement – Psychedelic Alpha

TORONTO, Aug. 21, 2023 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE:PSYG | OTCQB:PSYGF) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use

August 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.